Physician

Craig Dean Omohundro, MD

According to 2025 Medicare claims, Craig Omohundro, MD (NPI: 1457346850) practices dermatology in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is AFFILIATED DERMATOLOGY, PC (NPI: 1124008636; TIN: 63-1025971) and primary practice location at 36305-1306.

Omohundro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 595 traditional Medicare patients, billed 4,495 HCPCS/CPT codes, and received $411,376 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 614 prescription claims across 289 beneficiaries totaling $322,855 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 5 records totaling $99. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $174,800 to $322,855. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$270K$541K2015 Medicare payment: $540,723 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $539,893 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $461,041 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $458,687 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $538,044 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $452,915 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $413,185 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $495,565 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $495,086 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $411,376 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159817,590$540,723
20169248,034$539,893
20177826,554$461,041
20187656,229$458,687
20198416,366$538,044
20206695,392$452,915
20216535,088$413,185
20227115,302$495,565
20236845,149$495,086
20245954,495$411,376

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$186K$373K2015 Drug cost: $174,800 (USD; Tot_Drug_Cst)2016 Drug cost: $178,661 (USD; Tot_Drug_Cst)2017 Drug cost: $264,179 (USD; Tot_Drug_Cst)2018 Drug cost: $219,976 (USD; Tot_Drug_Cst)2019 Drug cost: $242,357 (USD; Tot_Drug_Cst)2020 Drug cost: $342,417 (USD; Tot_Drug_Cst)2021 Drug cost: $334,779 (USD; Tot_Drug_Cst)2022 Drug cost: $372,731 (USD; Tot_Drug_Cst)2023 Drug cost: $276,614 (USD; Tot_Drug_Cst)2024 Drug cost: $322,855 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015220510$174,800
2016192522$178,661
2017180486$264,179
2018196422$219,976
2019209510$242,357
2020222506$342,417
2021242627$334,779
2022266597$372,731
2023252561$276,614
2024289614$322,855

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks227298$418
11102Biopsy of related skin growth, first growth211302$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more437704$59
17000Destruction of precancer skin growth, 1 growth278418$34
17003Destruction of precancer skin growth, 2-14 growths2241,503$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa151,148$307,691
FluorouracilFluorouracil27800$2,430
CalcipotrieneCalcipotriene12345$2,009
Clobetasol PropionateClobetasol Propionate411,099$1,797
MetronidazoleMetronidazole22650$1,550

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$99LEO Pharma Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Craig Dean Omohundro, MD?

Tedicare shows public-source Medicare data for Craig Dean Omohundro, MD (NPI 1457346850), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Craig Dean Omohundro, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Craig Dean Omohundro, MD?

Craig Dean Omohundro, MD is linked to AFFILIATED DERMATOLOGY, PC (billing NPI 1124008636) in the available physician profile data.

Does Craig Dean Omohundro, MD have Open Payments data?

Craig Dean Omohundro, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.